Spots Global Cancer Trial Database for TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
Official Title: A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma in Patients With Portal Vein Thrombosis
Study ID: NCT01556282
Interventions
Study Description
Brief Summary: Therasphere will be administered via catheter through the Hepatic Artery to treat patients with Hepatocellular Carcinoma and Portal vein Thrombosis.
Detailed Description: Therasphere consists of glass microspheres containing a radioactive material called Yttrium-90. Therasphere is delivered into the liver tumor through a catheter placed into the hepatic artery which is the artery that provides the main blood supply to the tumor, this way delivering the radioactive material directly to the tumor and sparing the rest of the liver tissue from radiation.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Emory University Hospital, Atlanta, Georgia, United States
Contact Details
Name: Hyun s Kim, MD
Affiliation: Emory University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
